Literature DB >> 25646418

PTEN regulates natural killer cell trafficking in vivo.

Jeffrey W Leong1, Stephanie E Schneider1, Ryan P Sullivan1, Bijal A Parikh2, Bryan A Anthony1, Anvita Singh1, Brea A Jewell1, Timothy Schappe1, Julia A Wagner1, Daniel C Link1, Wayne M Yokoyama2, Todd A Fehniger3.   

Abstract

Phosphatase and tensin homolog (PTEN) is a critical negative regulator of the phosphoinositide-3 kinase pathway, members of which play integral roles in natural killer (NK) cell development and function. However, the functions of PTEN in NK cell biology remain unknown. Here, we used an NK cell-specific PTEN-deletion mouse model to define the ramifications of intrinsic NK cell PTEN loss in vivo. In these mice, there was a significant defect in NK cell numbers in the bone marrow and peripheral organs despite increased proliferation and intact peripheral NK cell maturation. Unexpectedly, we observed a significant expansion of peripheral blood NK cells and the premature egress of NK cells from the bone marrow. The altered trafficking of NK cells from peripheral organs into the blood was due to selective hyperresponsiveness to the blood localizing chemokine S1P. To address the importance of this trafficking defect to NK cell immune responses, we investigated the ability of PTEN-deficient NK cells to traffic to a site of tumor challenge. PTEN-deficient NK cells were defective at migrating to distal tumor sites but were more effective at clearing tumors actively introduced into the peripheral blood. Collectively, these data identify PTEN as an essential regulator of NK cell localization in vivo during both homeostasis and malignancy.

Entities:  

Keywords:  PTEN; cell migration; innate immunity; natural killer cell; phosphatase

Mesh:

Substances:

Year:  2015        PMID: 25646418      PMCID: PMC4343124          DOI: 10.1073/pnas.1413886112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene.

Authors:  Ralf Lesche; Matthias Groszer; Jing Gao; Ying Wang; Albee Messing; Hong Sun; Xin Liu; Hong Wu
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

Review 2.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

3.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor.

Authors:  Thierry Walzer; Laura Chiossone; Julie Chaix; Andrew Calver; Claude Carozzo; Laure Garrigue-Antar; Yannick Jacques; Myriam Baratin; Elena Tomasello; Eric Vivier
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

4.  p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.

Authors:  Aurore Saudemont; Fabien Garçon; Hakim Yadi; Marta Roche-Molina; Nayoung Kim; Anne Segonds-Pichon; Alfonso Martín-Fontecha; Klaus Okkenhaug; Francesco Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

5.  Dynamic behavior of NK cells during activation in lymph nodes.

Authors:  Hélène Beuneu; Jacques Deguine; Béatrice Breart; Ofer Mandelboim; James P Di Santo; Philippe Bousso
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

Review 6.  Natural killer cells: diversity in search of a niche.

Authors:  James P Di Santo
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 7.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

8.  The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion.

Authors:  Nayoung Kim; Aurore Saudemont; Louise Webb; Montserrat Camps; Thomas Ruckle; Emilio Hirsch; Martin Turner; Francesco Colucci
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

9.  The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse.

Authors:  Judith A Blake; Carol J Bult; Janan T Eppig; James A Kadin; Joel E Richardson
Journal:  Nucleic Acids Res       Date:  2013-11-26       Impact factor: 16.971

Review 10.  The trafficking of natural killer cells.

Authors:  Claude Grégoire; Lionel Chasson; Carmelo Luci; Elena Tomasello; Frédéric Geissmann; Eric Vivier; Thierry Walzer
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

View more
  19 in total

Review 1.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 2.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

3.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

4.  PTEN as a Guardian of the Genome: Pathways and Targets.

Authors:  Xinyi Fan; Jeffrey Kraynak; Jonathan P S Knisely; Silvia C Formenti; Wen H Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 6.915

5.  MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells.

Authors:  Melissa M Berrien-Elliott; Yaping Sun; Carly Neal; Aaron Ireland; Maria C Trissal; Ryan P Sullivan; Julia A Wagner; Jeffrey W Leong; Pamela Wong; Annelise Y Mah-Som; Terrence N Wong; Timothy Schappe; Catherine R Keppel; Victor S Cortez; Efstathios G Stamatiades; Ming O Li; Marco Colonna; Daniel C Link; Anthony R French; Megan A Cooper; Wei-Le Wang; Mark P Boldin; Pavan Reddy; Todd A Fehniger
Journal:  Immunity       Date:  2019-08-08       Impact factor: 31.745

6.  PTEN in Immunity.

Authors:  Antonella Papa; Pier Paolo Pandolfi
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

7.  Transcription factor KLF2 regulates homeostatic NK cell proliferation and survival.

Authors:  Whitney Rabacal; Sudheer K Pabbisetty; Kristen L Hoek; Delphine Cendron; Yin Guo; Damian Maseda; Eric Sebzda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

8.  The negative NK cell maturation checkpoint Foxo1.

Authors:  Youcai Deng; Jianhua Yu
Journal:  Oncotarget       Date:  2015-10-20

9.  NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation.

Authors:  Meixiang Yang; Shasha Chen; Juan Du; Junming He; Yuande Wang; Zehua Li; Guangao Liu; Wanwen Peng; Xiaokang Zeng; Dan Li; Panglian Xu; Wei Guo; Zai Chang; Song Wang; Zhigang Tian; Zhongjun Dong
Journal:  Nat Commun       Date:  2016-09-07       Impact factor: 14.919

10.  The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.

Authors:  Shoubao Ma; Jiazhuo Yan; Tasha Barr; Jianying Zhang; Zhenhua Chen; Li-Shu Wang; Joseph C Sun; Jianjun Chen; Michael A Caligiuri; Jianhua Yu
Journal:  J Exp Med       Date:  2021-06-23       Impact factor: 17.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.